ANVS vs DVA · $80.4M cap vs P/E 14, rev $12.82B
Annovis Bio Inc (ANVS) versus DaVita HealthCare Partners Inc (DVA) — a side-by-side from cached financials, not a winner call.
Annovis Bio Inc (ANVS) is a biotechnology company listed on US.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
Latest reported ANVS revenue for 2024-12-31 was $0. Net income was -$24.6M. ANVS currently screens at market cap $80.4M.
Latest reported DVA revenue for 2024-12-31 was $12.82B. Net income was $1.25B. Revenue was up 5.6% from 2023-12-31 to 2024-12-31. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
ANVS currently screens at market cap $80.4M. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
Not investment advice. Open the ANVS and DVA stock pages for the full models.
Not investment advice.